Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Eyelid Squamous Cell Carcinoma

Adrenocortical Carcinoma

Carcinoma, Non-Small-Cell Lung

Sinonasal Squamous Cell Carcinoma

Glioblastoma, Gliosarcoma

Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Basal Cell, Skin Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Skin Neoplasms

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

HPV-Related Squamous Cell Carcinoma

Carcinoma, Renal Cell

Metastatic Castration-resistant Prostate Cancer

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck

Skin Neoplasms

Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Advanced Squamous Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Hereditary Sensory and Autonomic Neuropathies

Solid Tumors

Urinary Bladder Neoplasms

Clinical Trials

CEMI-LUNG

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

ARCH

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

I-SPY

RAD-IO

CEMI-first

ANCHOR

TOP 2301: Neoadjuvant Chemo for NSCLC

A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

MINIMA

LAG-BOOST

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer

Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

GAP Cemi

N-PLANC

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

ICARS

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

CECYDE

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer